기본 정보
- 표준 SMILES
NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O- InChIKey
MKKYBZZTJQGVCD-XTCKQBCOSA-N- 분자식
- C22H44N6O10
- 평균 분자량
- 552.6 g/mol
- 단동위원소 질량
- 552.31189161
개요
Arbekacin is a kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring. It has a role as an antimicrobial agent, an antibacterial agent, an antibacterial drug and a protein synthesis inhibitor. It is a member of kanamycins and an aminoglycoside. It is functionally related to a kanamycin B.
이름 및 식별자
- 우선 이름
- Arbekacin
- IUPAC
- (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
- 영어명
- Arbekacin
- 분자식
- C22H44N6O10
- 분자량
- 552.62
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
51025-85-5- PubChem CID
- 68682
- DTXSID
DTXSID8048319- ChEMBL
CHEMBL426926- ChEBI
CHEBI:37922- UNII
- G7V6SLI20L
- Nikkaji
- J33.173B
물성
구조 계산 물성
- XLogP
- -6.8
- 극성 표면적
- 297 Ų
- 수소 결합 공여자 수
- 11
- 수소 결합 수용자 수
- 15
- 회전 가능 결합 수
- 10
- 무거운 원자 수
- 38
- 형식 전하
- 0
- 복잡도
- 757
실험 및 물리화학적 성질
물리화학적 성질
- 끓는 점
- 904 · 904.0±65.0 °C(Predicted)
- 밀도
- 1.47 · 1.47±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 13.07 · 13.07±0.70(Predicted)
안전 및 규제
독성 정보
Drug Induced Liver Injury
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
Arbekacin
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
화학 및 산업
약리 정보
ATC Code
J - Antiinfectives for systemic use
QJ - Antiinfectives for systemic use
Pharmacodynamics
Arbekacin is an aminoglycoside. Aminoglycosides function by binding to bacterial 30S ribosomal subunits, causing t-RNA misreads, and preventing the production of proteins. Anaerobes are less susceptible to aminoglycosides because they do not spend as much energy as aerobes on taking up chemicals like aminoglycosides. Aminoglycosides are useful primarily in infections involving aerobic, gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter.
Mechanism of Action
Arbekacin irreversibly binds bacterial 30S and 16S ribosomal subunits inhibiting protein synthesis. Arbekacin binds to 4 nucleotides of the 16S subunit and 1 amino acid of protein S12 to interfere with the decoding site around nucleotide 1400 in the 16S subunit. Interference with the decoding site interferes with its interaction with the wobble base of tRNA. This hindered interaction causes mRNA to be misread and the incorrect amino acids are inserted into protein. These error filled proteins are not able to function or may even be toxic.
응용 분야
개요Arbekacin is a semi-synthetic derivative of dibekacin useful in the treatment of bacterial infections. This aminoglycoside is active against a broad spectrum of bacteria, including some of the gentamycin-, kanamycin-, and tobramycin-resistant pathogens. Compared to amikacin and dibekacin, ototoxicity is reportedly milder.
상·하류 제품 정보
상류 원료
공급사32 곳
추가 설명
정의ChEBI: A kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring.
관련 반응
현재 필터 조건에 해당하는 반응 기록이 없습니다.
연결된 노트
불러오는 중…